Veeva Systems (VEEV) Stock News

Veeva Systems announced its Data Quality System has cleaned data for over 1 million subjects across more than 1,000 studies, using over 500,000 automated queries to save thousands of hours in data reconciliation.

Servier is adopting Veeva OpenData across more than 80 countries. The French pharmaceutical company aims to create a unified data foundation to scale AI initiatives. Veeva noted that 89% of AI initiatives fail due to data challenges.

Veeva Systems announced Study Builder Agent, an AI solution that configures its EDC and DQS systems directly from a study protocol. The company says it can set up clinical studies in as little as one day. Early adopter availability is planned for December 2026.

Oxford Biomedica, a cell and gene therapy CDMO, will implement Veeva Quality Cloud across its global manufacturing network in the UK, France, and US. The platform includes Veeva QualityDocs, QMS, Training, and Learn GxP to standardize processes and reduce manual workload.

Veeva Systems reported Q2 revenue of $928M (est. $905M) and adjusted EPS of $2.35 (est. $2.22). The company raised FY27 revenue guidance to $3.68B-$3.69B (est. $3.64B) and EPS guidance to ~$9.21 (est. $9.06). Q3 guidance also topped consensus. Management cited strong performance from Vault CRM and Veeva Falcon.